No Data
No Data
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (688505.SH): Core technical personnel Zhang Yifan resigns.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (688505.SH) announced that Zhang Yifan, the core technical personnel of the company, has applied for resignation due to personal reasons. Resignation...
shanghai fudan-zhangjiang bio-pharmaceutical co. ltd. (01349) will distribute a cash dividend of 0.02 yuan per share on August 30.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that the company will distribute a cash dividend of 0 per share on August 30, 2024.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (688505.SH) has no drugs involved in the treatment of monkeypox virus.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (688505.SH) stated on the interactive platform on August 20 that the company currently has no drugs related to the treatment of monkeypox virus. For specific business information and ongoing projects of the company, please refer to the periodic reports disclosed on the Shanghai Stock Exchange and the Hong Kong Stock Exchange websites.
Why Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd's (HKG:1349) Shaky Earnings Are Just The Beginning Of Its Problems
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. will distribute a mid-term dividend of 0.02 yuan per share on October 10.
Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co. Ltd. (01349) announced that it will distribute a mid-term dividend of RMB 0.02 per share as of June 30, 2024 on October 10, 2024.
Fudan-Zhangjiang Bio-Pharma's H1 Profit Marginally Increases as Revenue Plunges
No Data